GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Bronchitis affects the bronchial tubes, while pneumonia affects the lung air sacs. Without treatment, bronchitis can become pneumonia. You’re coughing, you’ve got a fever, and your chest feels ...

Pain relief medication can help manage symptoms until it resolves. Keep reading for more information on fever associated with bronchitis, treatment options, and more. The fever usually resolves ...

But often, pneumonia symptoms are more severe than those caused by bronchitis. Treatment will vary depending on whether a virus, bacteria, or fungus causes your illness. Practicing healthy ...

Bronchitis causes inflammation of the bronchi ... According to clinical practice guidelines, medications such as albuterol (and similar medications), epinephrine, and corticosteroids should ...

It's important to note that while acute bronchitis may lead to either bacterial or viral pneumonia, it does not lead to fungal or mycoplasma pneumonia. Receiving appropriate treatment for bronchitis ...

It's important to note that while acute bronchitis may lead to either bacterial or viral pneumonia, it does not lead to fungal or mycoplasma pneumonia. Receiving appropriate treatment for ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

“If your cough is not getting better after a week, it is a good idea to check in with your doctor,” says Eric Ascher, D.O., family medicine physician at Northwell Lenox Hill Hospital. But if your ...

These are the biggest signs that your cough is getting better according to Dr. Barrantes-Perez: “Symptoms also may not be as ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

Tozorakimab is under clinical development by AstraZeneca and currently in Phase II for Coronavirus Disease 2019 (COVID-19).